Table 6.
Cytokine | Sampling 1 | Sampling 2 | Sampling 3 | Sampling 4 | Sampling 5 | Group 2 (FIP) | Group 3 (SPF) |
---|---|---|---|---|---|---|---|
IL-1β | 48.2 | 59.3 | 76.1 | 71.6 | 92.5*§ | 34.0 | 53.4 |
38.0–58.0 | 54.0–68.2 | 76.1–81.8 | 59.6–80.8 | 88.1–93.2 | 27.4–60.6 | 48.8–54.7 | |
(32.3–62.6) | (53.3–78.8) | (76.0–86.9) | (48.7–89.0) | (77.7–93.7) | (21.5–84.4) | (44.7–55.8) | |
IL-4 | 20.7 | 18.0 | 51.9 | 32.0 | 41.0 | 0.0 | 0.0 |
0.0–43.1 | 0.0–36.6 | 37.6–65.9 | 16.0–36.4 | 29.8–44.3 | 0.0–10.2 | 0.0–0.0 | |
(0.0–47.9) | (0.0–38.0) | (51.1–79.1) | (1.6–40.4) | (3.0–49.8) | (0.0–19.4) | (0.0–0.0) | |
IL-6 | 0.0 | 0.0 | 16.7 | 0.0 | 0.0 | 0.0 | 0.0 |
0.0–0.0 | 0.0–0.0 | 0.0–25.1 | 0.0–0.0 | 0.0–10.4 | 0.0–13.6 | 0.0–0.0 | |
(0.0–0.0) | (0.0–0.0) | (0.0–47.6) | (0.0–0.0) | (0.0–38.6) | (0.0–25.8) | (0.0–0.0) | |
IL-10 | 0.0 | 26.6 | 6.6 | 0.0 | 0.0 | 0.0 | 0.0 |
0.0–0.0 | 0.0–54.5 | 0.0–9.9 | 0.0–0.0 | 0.0–0.0 | 0.0–0.0 | 0.0–0.0 | |
(0.0–0.0) | (0.0–57.8) | (0.0–18.7) | (0.0–0.0) | (0.0–0.0) | (0.0–0.0) | (0.0–0.0) | |
IL-12p40 | 27.7 | 0.0 | 54.4 | 52.4 | 77.3 | 0.0 | 0.0 |
0.0–56.9 | 0.0–0.0 | 45.5–60.3 | 51.0–52.6 | 54.4–84.0 | 0.0–39.4 | 0.0–0.0 | |
(0.0–61.0) | (0.0–0.0) | (48.2–71.2) | (49.7–52.8) | (5.4–89.4) | (0.0–74.8) | (0.0–0.0) | |
IFN-γ | 0.0 | 0.0 | 2.8 | 0.0 | 26.9*§ | 0.0 | 0.0 |
0.0–0.0 | 0.0–7.9 | 0.0–4.2 | 0.0–10.7 | 25.6–27.8 | 0.0–3.7 | 0.0–0.0 | |
(0.0–0.0) | (0.0–29.2) | (0.0–7.9) | (0.0–20.3) | (23.4–29.0) | (0.0–7.0) | (0.0–0.0) | |
TNF-α | 0.0 | 0.0 | 20.4 | 0.0 | 30.8 | 0.0 | 0.0 |
0.0–0.0 | 0.0–0.0 | 0.0–30.6 | 0.0–0.0 | 0.0–61.8 | 0.0–32.9 | 0.0–25.7 | |
(0.0–0.0) | (0.0–0.0) | (0.0–58.0) | (0.0–0.0) | (0.0–62.2) | (0.0–62.4) | (0.0–48.8) |
P<0.05 vs sampling 1.
P<0.01 vs FIP, SPF.